Skip to main content

. 1985 May;51(5):731–732. doi: 10.1038/bjc.1985.109

Reduced survival with radiotherapy and razoxane compared with radiotherapy alone for inoperable lung cancer in a randomised double-blind trial.

C E Newman, R Cox, C H Ford, J R Johnson, D R Jones, M Wheaton

PMCID: PMC1977056 PMID: 3888243

731

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bakowski M. T., Macdonald E., Mould R. F., Cawte P., Sloggem J., Barrett A., Dalley V., Newton K. A., Westbury G., James S. E. Double blind controlled clinical trial of radiation plus razoxane (ICRF 159) versus radiation plus placebo in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):115–119. doi: 10.1016/0360-3016(78)90125-6. [DOI] [PubMed] [Google Scholar]
Belloni C., Mangioni C., Bortolozzi G., Carinelli S., D'Incalci M., Maggioni A., Morasca L. ICRF 159 plus radiation versus radiation therapy alone in cervical carcinoma. A double-blind study. Oncology. 1983;40(3):181–185. doi: 10.1159/000225721. [DOI] [PubMed] [Google Scholar]
Freedman L. S., White S. J. On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. Biometrics. 1976 Sep;32(3):691–694. [PubMed] [Google Scholar]
Jones D. R., Newman C. E., Whitehead J. The design of a sequential clinical trial for the comparison of two lung cancer treatments. Stat Med. 1982 Jan-Mar;1(1):73–82. doi: 10.1002/sim.4780010110. [DOI] [PubMed] [Google Scholar]
Whitehead J., Jones D. R., Ellis S. H. The analysis of a sequential clinical trial for the comparison of two lung cancer treatments. Stat Med. 1983 Apr-Jun;2(2):183–190. doi: 10.1002/sim.4780020212. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES